Induction of apoptosis in B lymphoma cells by activation with CD40L

Acta Haematologica

Volumn 103, Issue 3, 2000, Pages 168-171

  Ova, Pet Ja Letter ^a,c   Marten, Angela ^b   Buttgereit, Peter ^a   Schakowski, Frank ^b   Micka, Bettina ^a   Scheffold, Christian ^b   Schmidt Wolf, Ingo G H ^a  

^a UNIVERSITY OF BONN   (Germany)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; HYBRID PROTEIN; MEMBRANE PROTEIN; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BIOSYNTHESIS; CANCER STEM CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; COCULTURE; CYTOLOGY; DRUG EFFECT; FIBROBLAST; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD40; ANTIGENS, CD80; APOPTOSIS; CD40 LIGAND; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; COCULTURE TECHNIQUES; FIBROBLASTS; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOMA, B-CELL; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTE SUBSETS; TRANSFECTION; TUMOR STEM CELLS;

EID: 0033642946     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000041042     Document Type: Article

References (12)

1. Koizumi T, Wang J, Suzuki Y, Masuda K, Watanabc T: Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4. Mol Immunol 1996;33:1247-1253.
2. Graf D, Korthauer U, Mages H\V, Scnger G, Kroczek RA: Cloning of TRAP, a ligand for CD40 on human T cells. Eur J Immunol 1992; 22:3191-3194.
3. Rothstein TL, Wang JK, Panka DJ, Foote LC, Wang Z, Stanger B, Cui H, Ju ST, MarshakRothstein A: Protection against Fas-dependent Thl-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995;374:163-165.
4. Laytragoon-Lewin N: Programmed cell death: The influence of CD40, CD95 (Fas or Apo-I) and their ligands. Med Oncol 1998;15/1:15-19.
5. Diehl L, den Boer AT, Schocnbergcr SP, van der Voort EIH, Schumacher TNM, Melief CJM, Offringa R, Toes REM: CD40 activation in vivo overcomes pcptide-induccd peripheral cytotoxic T-Iymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat Med 1999;5:774-779.
6. French RR, Claude Chan HT, Tutt AL, Glcnnie MJ: CD40 antibody evokes a cytotoxic Tccll response that eradicates lymphoma and bypasses T-ccll help. Nat Med 1999;5:548-553.
7. Schmidt-Wolf IGH, Negrin RS, Kiem HP, Blume KG, Weissman IL: Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. J Exp Med 1991;174/1:139-149.
8. Schmidt-Wolf IGH, Lefterova P, Johnston V, Neubauer A, Huhn D, Negrin R, Blume KG: Propagation of T cells with NK cell marker. Br J Haematol 1994;87:453-458.
9. Ebcrt O, Finkc S, Salahi A, Herrmann M, Trojancck B, Lefterova P, Wagner E, Kircheis R, Neubauer A, Huhn D, Schrievcr F, Wittig B, Schmidt-Wolf ICH: Lymphocyte apoptosis: Induction by gene transfer techniques. Gene Ther I997;4:296-302.
10. Wang H, Grand RJ, Milncr AE, Armitage RJ, Gordon J, Gregory CD: Repression of apoptosis in human B-lymphoma cells by CD40ligand and Bcl-2: Relationship to the cell-cycle and role of the retinoblastoma protein. Oncogene 1996;13:373-379.
11. Lens SM, Tesselaar K, den Drijver BF, van Oers MH, van Lier RA: A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death. J Immunol 1996;156:507-514.
12. Garronc P, Neidhardt EM, Garcia E, Galibcrt L, van Kooten C, Banchereau J: Fas ligation induces apoptosis of CD40-activatcd human B lymphocytes. J Exp Mcd 1995;182:1265-1273.